Here, we demonstrate that inhibition of VEGF binding to VEGFR2 with r84 is more effective than other anti-VEGF strategies in controlling breast tumor growth and the infiltration of immune suppressor cells. The gene discussed is KDR; the disease is breast neoplasm.